Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

This study has been completed.

Study NCT00027261 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: November 29, 2001 Last Updated: August 19, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given